Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAMP3 | O60896 | 15/20 | 0.52 |
| ▸ | CALCR | P30988 | 15/20 | 0.52 |
| ▸ | PLK1 | P53350 | 1/20 | 0.51 |
| ▸ | NMUR2 | Q9GZQ4 | 3/20 | 0.46 |
| ▸ | NMUR1 | Q9HB89 | 3/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30211026 | 0.98 | PLK1 (0.52) | RAMP3CALCRPLK1NMUR2NMUR1 | |
| SCHEMBL30211011 | 0.94 | PLK1 (0.52) | RAMP3CALCRPLK1NMUR2NMUR1 | |
| SCHEMBL30211041 | 0.90 | NMUR2 (0.53) | RAMP3CALCRPLK1NMUR2NMUR1 | |
| SCHEMBL30211030 | 0.90 | NMUR2 (0.53) | RAMP3CALCRPLK1NMUR2NMUR1 | |
| SCHEMBL5578209 | 0.89 | RAMP3 (0.59) | RAMP3CALCRNMUR2NMUR1 | |
| SCHEMBL5578210 | 0.89 | RAMP3 (0.59) | RAMP3CALCRNMUR2NMUR1 | |
| SCHEMBL5311106 | 0.89 | RAMP3 (0.57) | RAMP3CALCRNMUR2NMUR1 | |
| SCHEMBL5311116 | 0.89 | RAMP3 (0.57) | RAMP3CALCRNMUR2NMUR1 | |
| SCHEMBL30262325 | 0.89 | RAMP3 (0.51) | RAMP3CALCRPLK1NMUR2NMUR1 | |
| SCHEMBL29736175 | 0.87 | RAMP3 (0.58) | RAMP3CALCRNMUR2NMUR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117924419-A | Affinity peptide of targeted EGF receptor 2 and application thereof | 中国药科大学 | 2024-04-26 | — | — | CN | claimed |
| CN-117924419-A | Affinity peptide of targeted EGF receptor 2 and application thereof | 中国药科大学 | 2024-04-26 | — | — | CN | disclosed |